Healthcare

Healthcare expenditure in Asia-Pacific is expected to continue growing over the next 6 years, as rising demand for better healthcare for patients spurs reforms. This would also increase life expectancy, resulting in a large elderly population requiring long-term care. This study covers the hospital, life sciences, advanced medical technology, and c...

The study presents an outlook of the healthcare market in the Asia-Pacific. Good healthcare service can impact social issues, economics, and even the politics of a country. Governments need to meet these expectations, but rising costs in population and demographic shifts are causing them to falter. Disparity in care levels is also a concern, especi...

Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...

The dermatology space has been transformed with the introduction of biologic therapy for psoriasis, with several additional novel drug classes on the verge of market introduction. This research service provides a comprehensive overview and analysis of marketed and investigational products for the treatment of psoriasis. Information on market backg...

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

The primary aim of this study is to establish the size of laboratory budgets for the purchasing of products in 7 categories and the baselines for developing trends (2013 to 2014). Additionally, this research investigates the factors that drive selection of laboratory products and how these products are associated with factors driving selection. Ove...

Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...